BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: Comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 2009;29:636-40. [DOI: 10.1002/jmri.21689] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Albiin N. MRI of Focal Liver Lesions. Curr Med Imaging Rev. 2012;8:107-116. [PMID: 23049491 DOI: 10.2174/157340512800672216] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
2 Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, Kimura K, Sano K, Araki T. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology. 2011;260:446-453. [PMID: 21693662 DOI: 10.1148/radiol.11103548] [Cited by in Crossref: 120] [Cited by in F6Publishing: 95] [Article Influence: 10.9] [Reference Citation Analysis]
3 Hyodoh K, Hyodoh H, Kasahara M, Washio Y, Asai M, Hareyama M. Dynamic MR imaging of kidneys perfused with EOB-Gd-DTPA. Acta Chir Iugosl 2011;58:29-32. [PMID: 21630549 DOI: 10.2298/aci1101029h] [Reference Citation Analysis]
4 Choi SY, Kim SH, Jang KM, Kang TW, Song KD, Moon JY, Choi YH, Lee BR. The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses. Br J Radiol 2016;89:20160054. [PMID: 27164031 DOI: 10.1259/bjr.20160054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Ding Y, Rao SX, Wang WT, Chen CZ, Li RC, Zeng M. Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017). Cancer Imaging 2018;18:48. [PMID: 30526674 DOI: 10.1186/s40644-018-0183-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
6 Shin J, Lee S, Yoon JK, Chung YE, Choi J, Park M. LI‐RADS Major Features on MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis. J Magn Reson Imaging 2021;54:518-25. [DOI: 10.1002/jmri.27570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Fukukura Y, Kumagae Y, Fujisaki Y, Nakamura S, Dominik Nickel M, Imai H, Yoshiura T. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal adenocarcinoma. Eur J Radiol 2021;145:110036. [PMID: 34814039 DOI: 10.1016/j.ejrad.2021.110036] [Reference Citation Analysis]
8 Talakic E, Steiner J, Kalmar P, Lutfi A, Quehenberger F, Reiter U, Fuchsjäger M, Schöllnast H. Gd-EOB-DTPA enhanced MRI of the liver: Correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR. European Journal of Radiology 2014;83:607-11. [DOI: 10.1016/j.ejrad.2013.12.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
9 Qiao Z, Xia C, Shen S, Corwin FD, Liu M, Guan R, Grider JR, Qiao LY. Suppression of the PI3K pathway in vivo reduces cystitis-induced bladder hypertrophy and restores bladder capacity examined by magnetic resonance imaging. PLoS One 2014;9:e114536. [PMID: 25486122 DOI: 10.1371/journal.pone.0114536] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
10 Fujinaga Y, Ohya A, Matsushita T, Kurozumi M, Ueda K, Kitou Y, Ueda H, Kadoya M. Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA. Jpn J Radiol 2011;29:695-700. [DOI: 10.1007/s11604-011-0615-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Schalkx HJ, van Stralen M, Coenegrachts K, van den Bosch MAAJ, van Kessel CS, van Hillegersberg R, van Erpecum KJ, Verkooijen HM, Pluim JPW, Veldhuis WB, van Leeuwen MS. Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma. Eur Radiol 2014;24:2146-56. [DOI: 10.1007/s00330-014-3275-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
12 Besa C, Kakite S, Cooper N, Facciuto M, Taouli B. Comparison of gadoxetic acid and gadopentetate dimeglumine-enhanced MRI for HCC detection: prospective crossover study at 3 T. Acta Radiol Open 2015;4:2047981614561285. [PMID: 25793110 DOI: 10.1177/2047981614561285] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
13 Lee DH, Kim B, Lee ES, Kim HJ, Min JH, Lee JM, Choi MH, Seo N, Choi SH, Kim SH, Lee SS, Park YS, Chung YE; Korean Society of Abdominal Radiology. Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology. Korean J Radiol 2021;22:41-62. [PMID: 32901457 DOI: 10.3348/kjr.2019.0803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Zeng Z, Gao H, Chen C, Xiao L, Zhang K. Bioresponsive Nanomaterials: Recent Advances in Cancer Multimodal Imaging and Imaging-Guided Therapy. Front Chem 2022;10:881812. [DOI: 10.3389/fchem.2022.881812] [Reference Citation Analysis]
15 Bormann RL, da Rocha EL, Kierzenbaum ML, Pedrassa BC, Torres LR, D'Ippolito G. The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a review. Radiol Bras 2015;48:43-51. [PMID: 25798007 DOI: 10.1590/0100-3984.2013.1794] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
16 Motosugi U, Bannas P, Sano K, Reeder SB. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging 2015;41:251-65. [PMID: 25104398 DOI: 10.1002/jmri.24712] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
17 Tamada T, Ito K, Yamamoto A, Sone T, Kanki A, Tanaka F, Higashi H. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium. AJR Am J Roentgenol. 2011;196:824-830. [PMID: 21427331 DOI: 10.2214/ajr.10.5113] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
18 Min JH, Kim JM, Kim YK, Kim H, Cha DI, Kang TW, Choi GS, Choi SY, Ahn S. EASL versus LI-RADS: Intra-individual comparison of MRI with extracellular contrast and gadoxetic acid for diagnosis of small HCC. Liver Int 2021. [PMID: 34242468 DOI: 10.1111/liv.15012] [Reference Citation Analysis]
19 Kobi M, Paroder V, Flusberg M, Rozenblit A, Chernyak V. Limitations of GD-EOB-DTPA-enhanced MRI: can clinical parameters predict suboptimal hepatobiliary phase? Clinical Radiology 2017;72:55-62. [DOI: 10.1016/j.crad.2016.10.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
20 Davenport MS, Bashir MR, Pietryga JA, Weber JT, Khalatbari S, Hussain HK. Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. AJR Am J Roentgenol. 2014;203:796-802. [PMID: 25055154 DOI: 10.2214/ajr.13.11587] [Cited by in Crossref: 59] [Cited by in F6Publishing: 17] [Article Influence: 7.4] [Reference Citation Analysis]
21 Kanata N, Yoshikawa T, Ohno Y, Kanda T, Uchida K, Izaki K, Fukumoto T, Ku Y, Itoh T, Kitajima K, Takahashi S, Sugimura K. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT. Magnetic Resonance Imaging 2013;31:17-22. [DOI: 10.1016/j.mri.2012.06.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
22 Fujinaga Y, Ohya A, Tokoro H, Yamada A, Ueda K, Ueda H, Kitou Y, Adachi Y, Shiobara A, Tamaru N. Radial volumetric imaging breath-hold examination (VIBE) with k-space weighted image contrast (KWIC) for dynamic gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI of the liver: advantages over Cartesian VIBE in the arterial phase. Eur Radiol. 2014;24:1290-1299. [PMID: 24633374 DOI: 10.1007/s00330-014-3122-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
23 Huh J, Kim SY, Yeh BM, Lee SS, Kim KW, Wu EH, Wang ZJ, Zhao LQ, Chang WC. Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver. Korean J Radiol. 2015;16:1207-1215. [PMID: 26576109 DOI: 10.3348/kjr.2015.16.6.1207] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
24 Kierans AS, Makkar J, Guniganti P, Cornman-Homonoff J, Lee MJ, Pittman M, Askin G, Hecht EM. Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma. J Magn Reson Imaging. 2019;49:e205-e215. [PMID: 30257054 DOI: 10.1002/jmri.26329] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
25 Hwang J, Kim YK, Kim JM, Lee WJ, Choi D, Hong SS. Pretransplant diagnosis of hepatocellular carcinoma by gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging. Liver Transpl. 2014;20:1436-1446. [PMID: 25103727 DOI: 10.1002/lt.23974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
26 Tsuboyama T, Jost G, Kim T, Hori M, Onishi H, Pietsch H, Tomiyama N. Experimental studies on artifacts and tumor enhancement on gadoxetic acid-enhanced arterial phase liver MRI in a rabbit VX2 tumor model. Acta Radiol 2018;59:1029-37. [PMID: 29235879 DOI: 10.1177/0284185117747134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol. 2013;201:W603-W611. [PMID: 24059399 DOI: 10.2214/ajr.12.10262] [Cited by in Crossref: 49] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
28 Pahade JK, Juice D, Staib L, Israel G, Cornfeld D, Mitchell K, Weinreb J. Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies? Abdom Radiol (NY) 2016;41:1270-84. [PMID: 26800701 DOI: 10.1007/s00261-016-0635-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
29 Kijima S, Sasaki T, Nagata K, Utano K, Lefor AT, Sugimoto H. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. World J Gastroenterol 2014; 20(45): 16964-16975 [PMID: 25493009 DOI: 10.3748/wjg.v20.i45.16964] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
30 Kumar V, Boucher Y, Liu H, Ferreira D, Hooker J, Catana C, Hoover AJ, Ritter T, Jain RK, Guimaraes AR. Noninvasive Assessment of Losartan-Induced Increase in Functional Microvasculature and Drug Delivery in Pancreatic Ductal Adenocarcinoma. Transl Oncol 2016;9:431-7. [PMID: 27751347 DOI: 10.1016/j.tranon.2016.07.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
31 Agostini A, Kircher MF, Do RK, Borgheresi A, Monti S, Giovagnoni A, Mannelli L. Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions. Semin Roentgenol 2016;51:317-33. [PMID: 27743568 DOI: 10.1053/j.ro.2016.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
32 Chandarana H, Feng L, Ream J, Wang A, Babb JS, Block KT, Sodickson DK, Otazo R. Respiratory Motion-Resolved Compressed Sensing Reconstruction of Free-Breathing Radial Acquisition for Dynamic Liver Magnetic Resonance Imaging. Invest Radiol 2015;50:749-56. [PMID: 26146869 DOI: 10.1097/RLI.0000000000000179] [Cited by in Crossref: 68] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
33 Tamada T, Ito K, Sone T, Kanki A, Sato T, Higashi H. Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers. Eur J Radiol. 2011;80:e207-e211. [PMID: 20869827 DOI: 10.1016/j.ejrad.2010.08.033] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
34 Fujinaga Y, Ueda H, Kitou Y, Tsukahara Y, Sugiyama Y, Kadoya M. Time-intensity curve in the abdominal aorta on dynamic contrast-enhanced MRI with high temporal and spatial resolution: Gd-EOB-DTPA versus Gd-DTPA in vivo. Jpn J Radiol 2013;31:166-71. [PMID: 23179788 DOI: 10.1007/s11604-012-0162-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Kim MY, Kim YK, Park HJ, Park MJ, Lee WJ, Choi D. Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging? J Magn Reson Imaging. 2014;39:31-41. [PMID: 24115329 DOI: 10.1002/jmri.24122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
36 Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, Brouquet A, Adams RB; American Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12:289-299. [PMID: 20590901 DOI: 10.1111/j.1477-2574.2010.00181.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 99] [Article Influence: 10.1] [Reference Citation Analysis]
37 Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect? J Hepatol 2012;57:421-9. [PMID: 22504332 DOI: 10.1016/j.jhep.2012.01.031] [Cited by in Crossref: 245] [Cited by in F6Publishing: 207] [Article Influence: 24.5] [Reference Citation Analysis]
38 Aydın Tekdaş D, Garifullin R, Şentürk B, Zorlu Y, Gundogdu U, Atalar E, Tekinay AB, Chernonosov AA, Yerli Y, Dumoulin F, Guler MO, Ahsen V, Gürek AG. Design of a Gd-DOTA-Phthalocyanine Conjugate Combining MRI Contrast Imaging and Photosensitization Properties as a Potential Molecular Theranostic. Photochem Photobiol 2014;90:1376-86. [DOI: 10.1111/php.12332] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
39 Sagebiel T, Szkarluk J. Overview of CT and MRI Techniques of the Liver. In: Elsayes KM, editor. Cross-Sectional Imaging of the Abdomen and Pelvis. New York: Springer; 2015. pp. 1-9. [DOI: 10.1007/978-1-4939-1884-3_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Korkusuz H, Knau LL, Kromen W, Bihrer V, Keese D, Piiper A, Vogl TJ. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging. J Magn Reson Imaging 2012;35:1397-402. [PMID: 22267126 DOI: 10.1002/jmri.23584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
41 Tamada T, Ito K, Ueki A, Kanki A, Higaki A, Higashi H, Yamamoto A. Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver. J Magn Reson Imaging. 2012;35:852-858. [PMID: 22127980 DOI: 10.1002/jmri.23514] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
42 Hong SB, Lee NK, Kim S, Seo HI, Kim HS, Kim DU, Kim TU, Ryu HS. Modified CAIPIRINHA-VIBE without view-sharing on gadoxetic acid-enhanced multi-arterial phase MR imaging for diagnosing hepatocellular carcinoma: comparison with the CAIPIRINHA-Dixon-TWIST-VIBE. Eur Radiol 2019;29:3574-83. [PMID: 30993435 DOI: 10.1007/s00330-019-06095-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Narita K, Nakamura Y, Higaki T, Nishihara T, Harada K, Takizawa M, Shirase R, Bito Y, Akagi M, Honda Y, Iida M, Awai K. Utility of Radial Scanning for the Identification of Arterial Hypervascularity of Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced Magnetic Resonance Images. J Comput Assist Tomogr 2021;45:359-66. [PMID: 33661153 DOI: 10.1097/RCT.0000000000001139] [Reference Citation Analysis]
44 Tsurusaki M, Sofue K, Onishi H, Goshima S, Higaki A, Isoda H, Haradome H, Ishii K, Murakami T. Predictive factors of truncation artifacts in the arterial phase of Gd-EOB-DTPA-enhanced MRI: a nationwide multicenter study. Jpn J Radiol 2021;39:165-77. [PMID: 33025339 DOI: 10.1007/s11604-020-01052-x] [Reference Citation Analysis]
45 Sim KC, Park BJ, Han NY, Sung DJ, Kim MJ, Han YE. Effects of gadoxetic acid on image quality of arterial multiphase magnetic resonance imaging of liver: comparison study with gadoteric acid-enhanced MRI. Abdom Radiol (NY) 2019;44:4037-47. [PMID: 31471706 DOI: 10.1007/s00261-019-02202-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
46 Min JH, Kim JM, Kim YK, Cha DI, Kang TW, Kim H, Choi GS, Choi S, Ahn S. Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography. Clinical Gastroenterology and Hepatology 2020;18:2091-2100.e7. [DOI: 10.1016/j.cgh.2019.12.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
47 Chandarana H, Block TK, Ream J, Mikheev A, Sigal SH, Otazo R, Rusinek H. Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction. Invest Radiol 2015;50:88-94. [PMID: 25333309 DOI: 10.1097/RLI.0000000000000105] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 5.1] [Reference Citation Analysis]
48 Rimola J, Darnell A, Belmonte E, Sapena V, Caparroz C, Llarch N, Reig M, Forner A, Bruix J, Ayuso C. Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid. Eur Radiol 2020;30:6694-701. [DOI: 10.1007/s00330-020-07039-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Verloh N, Haimerl M, Rennert J, Müller-Wille R, Nießen C, Kirchner G, Scherer MN, Schreyer AG, Stroszczynski C, Fellner C. Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla. Eur J Radiol. 2013;82:1710-1715. [PMID: 23806531 DOI: 10.1016/j.ejrad.2013.05.033] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
50 Kupczyk PA, Willinek WA, Hadizadeh DR, Traeber F, Gieseke J, Meyer C, Schild HH, Kukuk GM. Abdominal vasculature in dynamic contrast-enhanced liver MRI at 3.0T: an intraindividual comparative study using gadoxetate disodium and gadofosveset trisodium. Magn Reson Imaging 2015;33:1258-66. [PMID: 26271178 DOI: 10.1016/j.mri.2015.08.001] [Reference Citation Analysis]
51 Lee J, Park CM, Kim KA, Lee CH, Choi JW. MR findings of focal eosinophilic liver disease using gadoxetic acid. Magn Reson Imaging 2010;28:1327-34. [PMID: 20800984 DOI: 10.1016/j.mri.2010.06.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
52 Ringe KI, Boll DT, Husarik DB, Bashir MR, Gupta RT, Merkle EM. Lesion detection and assessment of extrahepatic findings in abdominal MRI using hepatocyte specific contrast agents--comparison of Gd-EOB-DTPA and Gd-BOPTA. BMC Med Imaging 2013;13:10. [PMID: 23506523 DOI: 10.1186/1471-2342-13-10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
53 Maniam S, Szklaruk J. Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging. World J Radiol 2010; 2(8): 309-322 [PMID: 21160685 DOI: 10.4329/wjr.v2.i8.309] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
54 Miyamoto N, Yabusaki S, Sakamoto K, Kikuchi Y, Mimura R, Kato F, Oyama-Manabe N, Takahashi B, Soyama T, Abo D, Sakuhara Y, Kudo K, Shirato H, Nakamura T, Tsuchikawa T, Okamura K, Hirano S. Prediction of pancreatic anastomotic failure after pancreatic head resection using preoperative diffusion-weighted MR imaging. Jpn J Radiol 2015;33:59-66. [PMID: 25504055 DOI: 10.1007/s11604-014-0377-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
55 Kim B, Byun JH, Kim HJ, Won HJ, Kim SY, Shin YM, Kim PN. Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI. Eur Radiol 2016;26:191-8. [DOI: 10.1007/s00330-015-3798-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
56 Yim JH, Kim YK, Min JH, Lee J, Kang TW, Lee SJ. Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI. Abdom Radiol (NY) 2019;44:2366-76. [PMID: 30847566 DOI: 10.1007/s00261-019-01968-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 Park MJ, Kim YK, Lee MH, Lee JH. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis. Acta Radiol 2013;54:127-36. [PMID: 23148300 DOI: 10.1258/ar.2012.120262] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
58 Lin Y, Hwang R, Chen B, Hsu C, Yu C, Kao J, Lee H, Liang P, Wei S, Shih TT. Vascular and hepatic enhancements at MR imaging: comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects. Clinical Imaging 2014;38:287-91. [DOI: 10.1016/j.clinimag.2014.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
59 Grazioli L, Lee JM, Malfertheiner P, Zech CJ, Blomqvist L, Merkle EM. Consensus Report of the Third International Forum for Liver Magnetic Resonance Imaging: . Investigative Radiology 2010;45:S1-S10. [DOI: 10.1097/rli.0b013e3181fe7083] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
60 Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (& lt; or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol. 2010;45:96-103. [PMID: 20057319 DOI: 10.1097/rli.0b013e3181c5faf7] [Cited by in Crossref: 169] [Cited by in F6Publishing: 55] [Article Influence: 14.1] [Reference Citation Analysis]
61 Jang KM, Kim SH, Kim YK, Park MJ, Lee MH, Hwang J, Rhim H. Imaging features of small (≤3 cm) pancreatic solid tumors on gadoxetic-acid-enhanced MR imaging and diffusion-weighted imaging: an initial experience. Magnetic Resonance Imaging 2012;30:916-25. [DOI: 10.1016/j.mri.2012.02.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
62 Tamada T, Sone T, Jo Y, Hiratsuka J, Higaki A, Higashi H, Ito K. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors. AJR Am J Roentgenol. 2011;197:408-414. [PMID: 21785087 DOI: 10.2214/ajr.10.5772] [Cited by in Crossref: 45] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
63 Chen CZ, Rao SX, Ding Y, Zhang SJ, Li F, Gao Q, Zeng MS. Hepatocellular carcinoma 20 mm or smaller in cirrhosis patients: early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine. Hepatol Int 2014;8:104-11. [PMID: 26202411 DOI: 10.1007/s12072-013-9467-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
64 Wile GE, Leyendecker JR. Magnetic resonance imaging of the liver: sequence optimization and artifacts. Magn Reson Imaging Clin N Am 2010;18:525-47, xi. [PMID: 21094454 DOI: 10.1016/j.mric.2010.07.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
65 Davenport MS, Viglianti BL, Al-Hawary MM, Caoili EM, Kaza RK, Liu PS, Maturen KE, Chenevert TL, Hussain HK. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology. 2013;266:452-461. [PMID: 23192781 DOI: 10.1148/radiol.12120826] [Cited by in Crossref: 172] [Cited by in F6Publishing: 144] [Article Influence: 17.2] [Reference Citation Analysis]
66 Park HJ, Kim YK, Park MJ, Lee WJ. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 2013;38:793-801. [DOI: 10.1007/s00261-012-9943-x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
67 Min JH, Kim JM, Kim YK, Kang TW, Lee SJ, Choi GS, Choi SY, Ahn S. Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System. Hepatology 2018;68:2254-66. [PMID: 30070365 DOI: 10.1002/hep.30122] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 15.8] [Reference Citation Analysis]
68 Lim S, Kim YK, Park HJ, Lee WJ, Choi D, Park MJ. Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T. J Magn Reson Imaging. 2014;39:1238-1245. [PMID: 24136725 DOI: 10.1002/jmri.24265] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
69 Fahlenkamp UL, Wagner M, Nickel D, Adam U, Krueger K, Taupitz M, Schwenke C, Huppertz A. Novel Dynamic Hepatic Magnetic Resonance Imaging Strategy Using Advanced Parallel Acquisition, Rhythmic Breath-Hold Technique, and Gadoxetate Disodium Enhancement: . Investigative Radiology 2016;51:33-40. [DOI: 10.1097/rli.0000000000000203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Fehrenbach U, Kahn J, Fahlenkamp U, Baur A, Pavel M, Geisel D, Denecke T. Optimized imaging of the lower abdomen and pelvic region in hepatocyte-specific MRI: evaluation of a whole-abdomen first-pass shuttle protocol in patients with neuroendocrine neoplasms. Acta Radiol 2019;60:1074-83. [PMID: 30541328 DOI: 10.1177/0284185118817936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
71 Agnello F, Dioguardi Burgio M, Picone D, Vernuccio F, Cabibbo G, Giannitrapani L, Taibbi A, Agrusa A, Bartolotta TV, Galia M, Lagalla R, Midiri M, Brancatelli G. Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid. World J Gastroenterol 2016; 22(1): 103-111 [PMID: 26755863 DOI: 10.3748/wjg.v22.i1.103] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
72 Noda Y, Goshima S, Takai Y, Kawai N, Kawada H, Tanahashi Y, Matsuo M. Detection of pancreatic ductal adenocarcinoma and liver metastases: comparison of Gd-EOB-DTPA-enhanced MR imaging vs. extracellular contrast materials. Abdom Radiol (NY) 2020;45:2459-68. [PMID: 32248260 DOI: 10.1007/s00261-020-02511-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology. 2013;266:376-382. [PMID: 23362092 DOI: 10.1148/radiol.12121698] [Cited by in Crossref: 258] [Cited by in F6Publishing: 234] [Article Influence: 28.7] [Reference Citation Analysis]
74 Almeida MC, Netto RORF, Melo JIF, Fernandes VAR, Manfredini RC, Dutra LD. Evaluation of hepatic findings by magnetic resonance after use of gadoxetic acid. Prec Radiat Oncol 2021;5:18-24. [DOI: 10.1002/pro6.1112] [Reference Citation Analysis]
75 Choi ES, Kim JS, Nickel MD, Sung JK, Lee JK. Free-breathing contrast-enhanced multiphase MRI of the liver in patients with a high risk of breath-holding failure: comparison of compressed sensing-accelerated radial and Cartesian acquisition techniques. Acta Radiol 2021;:2841851211052988. [PMID: 34839679 DOI: 10.1177/02841851211052988] [Reference Citation Analysis]
76 Cha DI, Choi GS, Kim YK, Kim JM, Kang TW, Song KD, Ahn SH. Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS. Eur Radiol 2020;30:3723-34. [DOI: 10.1007/s00330-020-06753-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
77 Huang Y, He S, Cao W, Cai K, Liang X. Biomedical nanomaterials for imaging-guided cancer therapy. Nanoscale 2012;4:6135. [DOI: 10.1039/c2nr31715j] [Cited by in Crossref: 142] [Cited by in F6Publishing: 126] [Article Influence: 14.2] [Reference Citation Analysis]
78 Kurozumi M, Fujinaga Y, Kitou Y, Yamada A, Ohya A, Adachi Y, Tsukahara Y, Nickel MD, Maruyama K, Uehara T, Miyagawa SI, Kadoya M. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography. Jpn J Radiol 2018;36:295-302. [PMID: 29327116 DOI: 10.1007/s11604-018-0720-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
79 Tamada T, Ito K, Higaki A, Yoshida K, Kanki A, Sato T, Higashi H, Sone T. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol. 2011;80:e311-e316. [PMID: 21315529 DOI: 10.1016/j.ejrad.2011.01.020] [Cited by in Crossref: 118] [Cited by in F6Publishing: 100] [Article Influence: 10.7] [Reference Citation Analysis]
80 Thian YL, Riddell AM, Koh DM. Liver-specific agents for contrast-enhanced MRI: role in oncological imaging. Cancer Imaging. 2013;13:567-579. [PMID: 24434892 DOI: 10.1102/1470-7330.2013.0050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
81 Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Nakayama T, Morita K, Ishimatsu K, Honda H. Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid–enhanced MRI: Imaging Appearances and Clinical Importance. RadioGraphics 2020;40:72-94. [DOI: 10.1148/rg.2020190037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
82 Tirkes T, Mehta P, Aisen AM, Lall C, Akisik F. Comparison of Dynamic Phase Enhancement of Hepatocellular Carcinoma Using Gadoxetate Disodium vs Gadobenate Dimeglumine. J Comput Assist Tomogr 2015;39:479-82. [PMID: 25783800 DOI: 10.1097/RCT.0000000000000234] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
83 Ha S, Lee CH, Kim BH, Park YS, Lee J, Choi JW, Kim KA, Park CM. Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the “target sign” a common finding? Magn Reson Imaging. 2012;30:1083-1090. [PMID: 22578929 DOI: 10.1016/j.mri.2012.03.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]